425 related articles for article (PubMed ID: 21598298)
1. Thienopyrimidines as novel inhibitors of Mycobacterium tuberculosis: synthesis and in-vitro studies.
Rashmi P; Nargund LV; Hazra K; Chandra JN
Arch Pharm (Weinheim); 2011 Jul; 344(7):459-65. PubMed ID: 21598298
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.
Chhabria MT; Jani MH
Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents.
Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C
Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496
[TBL] [Abstract][Full Text] [Related]
4. Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines.
Trivedi A; Dodiya D; Surani J; Jarsania S; Mathukiya H; Ravat N; Shah V
Arch Pharm (Weinheim); 2008 Jul; 341(7):435-9. PubMed ID: 18574851
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimycobacterial evaluation of N-substituted 3-aminopyrazine-2,5-dicarbonitriles.
Zitko J; Jampílek J; Dobrovolný L; Svobodová M; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2012 Feb; 22(4):1598-601. PubMed ID: 22281187
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro anticancer and antitubercular activity of diarylpyrazole ligated dihydropyrimidines possessing lipophilic carbamoyl group.
Yadlapalli RK; Chourasia OP; Vemuri K; Sritharan M; Perali RS
Bioorg Med Chem Lett; 2012 Apr; 22(8):2708-11. PubMed ID: 22437116
[TBL] [Abstract][Full Text] [Related]
8. Novel dihydropyrimidines as a potential new class of antitubercular agents.
Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
[TBL] [Abstract][Full Text] [Related]
9. A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents.
Agarwal A; Srivastava K; Puri SK; Sinha S; Chauhan PM
Bioorg Med Chem Lett; 2005 Dec; 15(23):5218-21. PubMed ID: 16171994
[TBL] [Abstract][Full Text] [Related]
10. Facile transformation of Biginelli pyrimidin-2(1H)-ones to pyrimidines. In vitro evaluation as inhibitors of Mycobacterium tuberculosis and modulators of cytostatic activity.
Singh K; Singh K; Wan B; Franzblau S; Chibale K; Balzarini J
Eur J Med Chem; 2011 Jun; 46(6):2290-4. PubMed ID: 21450375
[TBL] [Abstract][Full Text] [Related]
11. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
Abdel-Rahman HM; El-Koussi NA; Hassan HY
Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of mycobacterial replication by pyrimidines possessing various C-5 functionalities and related 2'-deoxynucleoside analogues using in vitro and in vivo models.
Srivastav NC; Rai D; Tse C; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2010 Aug; 53(16):6180-7. PubMed ID: 20718497
[TBL] [Abstract][Full Text] [Related]
13. Novel amide and sulphonamide derivatives of 6-(piperazin-1-yl)phenanthridine as potent Mycobacterium tuberculosis H37Rv inhibitors.
Naidu KM; Nagesh HN; Singh M; Sriram D; Yogeeswari P; Gowri Chandra Sekhar KV
Eur J Med Chem; 2015 Mar; 92():415-26. PubMed ID: 25590862
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
Sirisha K; Bikshapathi D; Achaiah G; Reddy VM
Eur J Med Chem; 2011 May; 46(5):1564-71. PubMed ID: 21382653
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of anti-Mycobacterium tuberculosis agents.
Bacelar AH; Carvalho MA; Proença MF
Eur J Med Chem; 2010 Jul; 45(7):3234-9. PubMed ID: 20416983
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
18. A green expedient synthesis of pyridopyrimidine-2-thiones and their antitubercular activity.
Rajesh SM; Kumar RS; Libertsen LA; Perumal S; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2011 May; 21(10):3012-6. PubMed ID: 21498077
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antimycobacterial evaluation of pyrazinamide derivatives with benzylamino substitution.
Zitko J; Paterová P; Kubíček V; Mandíková J; Trejtnar F; Kuneš J; Doležal M
Bioorg Med Chem Lett; 2013 Jan; 23(2):476-9. PubMed ID: 23237840
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel [1,2]-diamines with antituberculosis activity.
Meng Q; Luo H; Chen Y; Wang T; Yao Q
Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]